Quarterly visits during maintenance: weight check, lab review, plan adjustment
Storage must follow the sponsor's IMPD or Investigator's Brochure
That is the first non-surgical intervention to match the low end of bariatric outcomes (~25-35% total body weight loss), and it happened in a population with obesity and knee osteoarthritis, the exact patient who until 2026 had no good option
Ozempic ( semaglutide GLP-1 ) is one of the most effective GLP-1 medications for weight loss , often leading to significant results in appetite reduction and fat loss
"Effects of retatrutide on body composition in people with type 2 diabetes: a substudy of a phase 2, double-blind, parallel-group, placebo-controlled, randomised trial." Obesity Research & Clinical Practice
So it is an identity and you want to own that identity